Michael Lotze
![Michael Lotze Michael Lotze](https://til-therapies.com/wp-content/uploads/sites/262/2024/05/Michael-Lotze-speaker-150x150.png)
Company: UPitt
Job title: Professor & Assistant Vice Chancellor of Surgery, Immunology & Bioengineering, Sponsored Training Grants
Seminars:
Roundtable: Aligning Industry & Academic Establishments to Accelerate TIL Discovery 2:30 pm
Increasing access to tissue samples, clinical and real-life data to empower R&D efforts Evaluating key opportunities in partnerships between clinical institutions and industry Discussing hurdles in academia and industry to the spread of data and publishing of results to advance shared knowledge of TILsRead more
day: Conference Day One - Track A - PM
Exploring the Characteristics of Gamma Delta TIL to Treat Patients with Solid Tumors 4:00 pm
Epithelial normally serve as mucosal barriers, sites for selective transport and harbor immune cells including gamma delta T-cells Gamma delta T-cells diminish with age, coincident with increased epithelial tumor cells Gamma delta TIL specifically recognize autologous tumor equivalent or better than alpha beta TILRead more
day: Conference Day Two